Donor cells train body to fight cancer in advanced colon cancer trial
NCT ID NCT04444622
Summary
This study tested an experimental immunotherapy called STIMVAX for people with advanced colorectal cancer that had stopped responding to two previous chemotherapy treatments. The treatment uses specially prepared immune cells from healthy donors to try to teach the patient's own immune system to recognize and attack their cancer. Researchers measured whether this approach was safe and if it helped patients live longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hirschfield Oncology Center
The Bronx, New York, 10469, United States
-
Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
-
Mt. Sinai Comprehensive Cancer Center
Miami Beach, Florida, 33140, United States
-
Summit Health
Florham Park, New Jersey, 07932, United States
Conditions
Explore the condition pages connected to this study.